跳转至内容
Merck
CN
  • Effect of muscle weakness and joint inflammation on the onset and progression of osteoarthritis in the rabbit knee.

Effect of muscle weakness and joint inflammation on the onset and progression of osteoarthritis in the rabbit knee.

Osteoarthritis and cartilage (2014-08-12)
C Egloff, A Sawatsky, T Leonard, D A Hart, V Valderrabano, W Herzog
摘要

Interactions between mechanical and non-mechanical independent risk factors for the onset and progression of Osteoarthritis (OA) are poorly understood. Therefore, the goal of the present study was to investigate the in vivo effects of muscle weakness, joint inflammation and the combination on the onset and progression of OA in a rabbit knee joint model. Thirty 1-year-old female New Zealand White rabbits (average 5.7 kg, range 4.8-6.6 kg) were divided into four groups with one limb randomly assigned to be the experimental side: (1) surgical denervation of the vastus lateralis (VL) muscle; (2) muscle weakness induced by intramuscular injection of Botulinum toxin A (BTX-A); (3) intraarticular injection with Carrageenan to induce a transient inflammatory reaction; (4) combination of Carrageenan and BTX-A injection. After 90 days, cartilage histology of the articular surfaces were microscopically analyzed using the Osteoarthritis Research Society International (OARSI) histology scoring system. VL denervation resulted in significantly higher OARSI scores in the patellofemoral joint (group 1). BTX-A administration resulted in significant cartilage damage in all four compartments of the knee (group 2). Carrageenan did not cause significant cartilage damage. BTX-A combined with Carrageenan lead to severe cartilage damage in all four compartments. Muscle weakness lead to significant OA in the rabbit knee. A transient local inflammatory stimulus did not promote cartilage degradation nor did it enhance OA progression when combined with muscle weakness. These results are surprising and add to the literature the conclusion that acute inflammation is probably not an independent risk factor for OA in this rabbit model.

材料
产品编号
品牌
产品描述

Sigma-Aldrich
乙醇,Pure 200纯度, Molecular Biology
Sigma-Aldrich
纯乙醇, 200 proof, ACS reagent, ≥99.5%
Sigma-Aldrich
纯乙醇, 200 proof
Sigma-Aldrich
纯乙醇, 200 proof, meets USP testing specifications
Sigma-Aldrich
纯乙醇, 200 proof, anhydrous, ≥99.5%
Sigma-Aldrich
甲醛 溶液, Molecular Biology, 36.5-38% in H2O
Sigma-Aldrich
乙醇,Pure 190纯度, for molecular biology
Sigma-Aldrich
邻二甲苯, puriss. p.a., ≥99.0% (GC)
Sigma-Aldrich
甲醛 溶液, ACS reagent, 37 wt. % in H2O, contains 10-15% Methanol as stabilizer (to prevent polymerization)
SAFC
甲醛 溶液, contains 10-15% methanol as stabilizer, 37 wt. % in H2O
Sigma-Aldrich
纯乙醇, 190 proof, ACS spectrophotometric grade, 95.0%
Sigma-Aldrich
酒精, BioUltra, Molecular Biology, ≥99.8%, (absolute alcohol, without additive, A15 o1)
Sigma-Aldrich
邻二甲苯, reagent grade, ≥98.0%
Sigma-Aldrich
甲醛 溶液, Molecular Biology, BioReagent, ≥36.0% in H2O (T)
Supelco
无水乙醇, Pharmaceutical Secondary Standard; Certified Reference Material
Sigma-Aldrich
纯乙醇, 190 proof, meets USP testing specifications
Supelco
酒精, standard for GC
Supelco
邻二甲苯, suitable for HPLC, 98%
Sigma-Aldrich
甲醛 溶液, meets analytical specification of USP, ≥34.5 wt. %
Sigma-Aldrich
邻二甲苯, anhydrous, 97%
Supelco
甲醛 溶液, stabilized with methanol, ~37 wt. % in H2O, certified reference material
Sigma-Aldrich
甲酸, ≥95%, FCC, FG
Sigma-Aldrich
酒精, puriss. p.a., absolute, ≥99.8% (GC)
Sigma-Aldrich
甲醛 溶液, tested according to Ph. Eur.
Supelco
Ethanol 溶液, certified reference material, 2000 μg/mL in methanol
Supelco
邻二甲苯, analytical standard
Sigma-Aldrich
酒精, tested according to Ph. Eur.
Supelco
10% (v/v) 乙醇标准品, 10 % (v/v) in H2O, analytical standard
USP
无水酒精, United States Pharmacopeia (USP) Reference Standard
Sigma-Aldrich
甲酸 溶液, BioUltra, 1.0 M in H2O